19 diciembre 2014
Aiming to increase treatment options for prostate cancer patients who have an early relapse, investigators from a multi-institutional cooperative group have demonstrated that a vaccine therapy that stimulates the body’s own immune defenses can be given safely and earlier in the course of prostate cancer progression.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/QWSuwCcy7TE/141219160502.htm
